Axillary Hyperhidrosis Pipeline Review, H1 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Axillary Hyperhidrosis - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Axillary Hyperhidrosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Axillary Hyperhidrosis and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Axillary Hyperhidrosis Overview
  3. Therapeutics Development
  4. Pipeline Products for Axillary Hyperhidrosis - Overview
  5. Pipeline Products for Axillary Hyperhidrosis - Comparative Analysis
  6. Axillary Hyperhidrosis - Therapeutics under Development by Companies
  7. Axillary Hyperhidrosis - Therapeutics under Investigation by Universities/Institutes
  8. Axillary Hyperhidrosis Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Axillary Hyperhidrosis - Products under Development by Companies
  13. Axillary Hyperhidrosis - Products under Investigation by Universities/Institutes
  14. Axillary Hyperhidrosis - Companies Involved in Therapeutics Development
  • Allergan Plc
  • Brickell Biotech, Inc.
  • Dermira Inc.
  • GlaxoSmithKline Plc
  • Revance Therapeutics, Inc.
  • TheraVida, Inc.

For more information visit http://www.researchandmarkets.com/research/xjbtzf/axillary

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Immune Disorders Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Immune Disorders Drugs